Navigation Links
NJLRA Statement in Response to Roche's Discontinuation of Accutane(R)
Date:6/26/2009

TRENTON, N.J., June 26 /PRNewswire/ -- Marcus Rayner, executive director of the New Jersey Lawsuit Reform Alliance, a statewide, bipartisan group of individuals, businesses and organizations dedicated to improving the state's civil justice system and advocating for legal reform in the legislature and in the courts, today issued the following statement in reaction to Roche's announcement that the company will immediately discontinue Accutane(R), a treatment for severe acne:

"Thanks to an aggressive, self-interested campaign by personal injury lawyers, an important medical breakthrough deemed safe and effective by the U.S. Food and Drug Administration and that helped more than 13 million patients treat severe acne was voluntarily removed from the market today by the manufacturer. This leaves millions of patients around the world with fewer treatment options.

"New Jersey companies lead the world in discovering medical innovations like Accutane(R), which have improved the quality of life of millions. But the high cost of frivolous lawsuits -- like the Accutane(R) cases being tried in New Jersey -- threatens medical progress.

"The trial bar shouldn't leave patients out in the cold. NJLRA will continue to fight for common sense reforms that improve our courts and protect patients."

    Contact: Marcus Rayner
    (609) 651-3774
    mrayner@njlra.org


'/>"/>
SOURCE New Jersey Lawsuit Reform Alliance
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
2. AAHSA Statement on Long-Term Services and Supports CBO Scoring
3. AAHSA Statement on House Ways and Means Committee Hearing
4. Statement of Dr. Elena Rios, MD, MSPH, President and CEO, National Hispanic Medical Association
5. Phyhealth Issues 2008 Audited Financial Statements and Provides Business Update
6. Pelosi Statement on President Obama Signing Smoking Prevention and Tobacco Control Act
7. PhRMA Statement on Medicare Part D Coverage Gap
8. Pelosi Statement on House Committee Chairmens Draft Health Care Reform Proposal
9. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
10. National Changing Diabetes Program Issues Statement on President Obamas Speech to the American Medical Association
11. Statement of James P. Firman President and CEO, National Council on Aging on World Elder Abuse Awareness Day June 15, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... On May 23rd during the National ... Science® and international water advocate, was honored by Ashram, Inc. as the world’s foremost ... who knelt on the banks of the Nile to fill their red clay pots ...
(Date:5/26/2016)... ... May 26, 2016 , ... Saint Francis ... several years, and the efforts have paid off. Since implementation of these ... of care to enhance perioperative patient experiences and reduce costly complications. Since implementation ...
(Date:5/26/2016)... Viejo, California (PRWEB) , ... May 26, 2016 , ... ... Transition Plugin for FCPX. , "This new layered style transition tool will ... said Christina Austion - CEO of Pixel Film Studios. , TranSweep is an ...
(Date:5/26/2016)... ... May 26, 2016 , ... TopConsumerReviews.com recently awarded their ... . , High blood pressure affects millions of people worldwide, and many patients ... lead to heart disease, stroke, kidney disease, and hardening of the arteries. However, ...
(Date:5/25/2016)... ... , ... The United States Food and Drug Administration (FDA) has now cleared ... To date, the company is the first and only manufacturer of low level laser ... androgenetic alopecia. , “This new level of clearance substantiates what many physicians have ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... de doble terapia del mundo, introduce catéteres para ... OrbusNeich, una compañía global especializada en ... vidas, ha expandido su cartera incluyendo productos para ... JADE™ y Scoreflex™ PTA son los dispositivos de ...
(Date:5/24/2016)... 2016 Een app die artsen ... collectief patiënten kunnen behandelen, hun kennis kunnen delen en ... de nieuwe en revolutionaire MDLinking App, ontwikkeld door een ... dr. Hans Flu en oncologisch chirurg dr. Gijs ... is, wordt op dinsdag 24 mei officieel gepresenteerd op ...
(Date:5/23/2016)... ALBANY, New York , May 23, 2016 /PRNewswire/ ... new market report titled, " Exocrine Pancreatic Insufficiency Market ... Forecast 2013 - 2023 ." According to the report, ... at a CAGR of 8.3% from 2015 to 2023 ... pancreatic insufficiency (EPI) is a condition characterized by the ...
Breaking Medicine Technology: